NCT04037618View on ClinicalTrials.gov

Mass Balance Study to Investigate the Absorption, Metabolism and Excretion of [14C]-EYP001a After a Single Oral Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 24, 2019

Primary Completion Date

July 27, 2019

Study Completion Date

August 6, 2019

Conditions
Healthy
Interventions
DRUG

[14C]-EYP001a

Oral drinking suspension

Trial Locations (1)

9713

QPS Netherlands B.V., Groningen

Sponsors

Lead Sponsor

Enyo Pharma
All Listed Sponsors
lead

Enyo Pharma

INDUSTRY